Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 616

    Article Cited by others

ORIGINAL ARTICLE

Coexistence of her2, ki67, and p53 in osteosarcoma: A strong prognostic factor

Mardanpour Keykhosro, Rahbar Mahtab, Mardanpour Sourena

Year : 2016| Volume: 8| Issue : 5 | Page no: 210-214

   This article has been cited by
 
1 miR-135a Targets SMAD2 to Promote Osteosarcoma Proliferation and Migration
Yuanyuan Chen, Bin Cai, Xiaofeng Lian, Jianguang Xu, Tao Zhang, Wei long Zhong
Journal of Oncology. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
2 Improving Osteosarcoma Treatment: Comparative Oncology in Action
Lidia Tarone, Katia Mareschi, Elisa Tirtei, Davide Giacobino, Mariateresa Camerino, Paolo Buracco, Emanuela Morello, Federica Cavallo, Federica Riccardo
Life. 2022; 12(12): 2099
[Pubmed]  [Google Scholar] [DOI]
3 Clinicopathological assessment of cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma
Kazuhiko Hashimoto, Shunji Nishimura, Tomohiko Ito, Naohiro Oka, Ryosuke Kakinoki, Masao Akagi
European Journal of Histochemistry. 2022; 66(3)
[Pubmed]  [Google Scholar] [DOI]
4 A case of osteosarcoma of the mandible treated with surgical resections for pulmonary metastases
Eri SHIBATA,Kohei OKUYAMA,Yasuyuki MICHI,Kei SAKAMOTO,Hiroyuki HARADA,Tetsuya YODA
Japanese Journal of Oral and Maxillofacial Surgery. 2021; 67(6): 353
[Pubmed]  [Google Scholar] [DOI]
5 Curcumin inhibits the proliferation and migration of vascular smooth muscle cells by targeting the chemerin / CMKLR1 / LCN2 axis
Yaqiong He,Rongning Wang,Peng Zhang,Jianlong Yan,Nan Gong,Yuhang Li,Shaohong Dong
Aging. 2021; 13(10): 13859
[Pubmed]  [Google Scholar] [DOI]
6 Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines
Jordan Ayers,Rowan J. Milner,Galaxia Cortés-Hinojosa,Alberto Riva,Sandra Bechtel,Bikash Sahay,Matthew Cascio,Amandine Lejeune,Keijiro Shiomitsu,Carlos Souza,Oscar Hernandez,Marc Salute
Journal of Veterinary Diagnostic Investigation. 2021; 33(2): 261
[Pubmed]  [Google Scholar] [DOI]
7 The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
Ming Zeng,Jian Zhou,Lifang Wen,Yanshan Zhu,Yingquan Luo,Wanchun Wang
BMC Cancer. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
8 Is immunotherapy in the future of therapeutic management of sarcomas?
Ottavia Clemente,Alessandro Ottaiano,Giuseppe Di Lorenzo,Alessandra Bracigliano,Sabrina Lamia,Lucia Cannella,Antonio Pizzolorusso,Massimiliano Di Marzo,Mariachiara Santorsola,Annarosaria De Chiara,Flavio Fazioli,Salvatore Tafuto
Journal of Translational Medicine. 2021; 19(1)
[Pubmed]  [Google Scholar] [DOI]
9 PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis
Yu-Hang Li,Kui-Leung Tong,Jun-Lei Lu,Jie-Bin Lin,Zhen-Yan Li,Yuan Sang,Abdelmoumin Ghodbane,Xue-Juan Gao,Man-Seng Tam,Chang-Deng Hu,Huan-Tian Zhang,Zhen-Gang Zha
Aging. 2020; 12(3): 2507
[Pubmed]  [Google Scholar] [DOI]
10 Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms
Hélios Bertin,A. Gomez-Brouchet,F. Rédini
Critical Reviews in Oncology/Hematology. 2020; 156: 103126
[Pubmed]  [Google Scholar] [DOI]
11 Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications
Pichaya Thanindratarn,Dylan C. Dean,Scott D. Nelson,Francis J. Hornicek,Zhenfeng Duan
Cancer Treatment Reviews. 2020; 82: 101934
[Pubmed]  [Google Scholar] [DOI]
12 A rare case of a metastatic giant cell-rich osteosarcoma of the mandible: update and differential diagnostic considerations
Lucas Alves da Mota Santana,Fernanda Aragão Felix,José Alcides Almeida de Arruda,Leorik Pereira da Silva,Érika de Abreu Costa Brito,Wilton Mitsunari Takeshita,Cleverson Luciano Trento
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
13 Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421
Ji-Hai Wang, Xue-Jian Wu, Yong-Zhuang Duan, Feng Li
Cell Transplantation. 2020; 29: 0963689720
[Pubmed]  [Google Scholar] [DOI]
14 Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR
Wenwei Jiang, Xinyu Cai, Tianyang Xu, Kaiyuan Liu, Dong Yang, Lin Fan, Guodong Li, Xiao Yu
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2020; 28(4): 409
[Pubmed]  [Google Scholar] [DOI]
15

SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway

Zhiqiang Wu,Chunmeng Wang,Yong Chen,Zhengwang Sun,Wangjun Yan
OncoTargets and Therapy. 2020; Volume 13: 1737
[Pubmed]  [Google Scholar] [DOI]
16 Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience
Brittany L. Siontis,Jonathan B. McHugh,Emily Roberts,Lily Zhao,Dafydd G. Thomas,Dawn Owen,Laurence H. Baker,J. Sybil Biermann,Scott M. Schuetze,Rashmi Chugh
Frontiers in Oncology. 2020; 9
[Pubmed]  [Google Scholar] [DOI]
17 Overexpression of miR-335 inhibits the migration and invasion of osteosarcoma by targeting SNIP1
Yuanlong Xie,Huaxin Deng,Renxiong Wei,Wenchao Sun,Yongjian Qi,Shiyi Yao,Lin Cai,Yan Wang,Zhouming Deng
International Journal of Biological Macromolecules. 2019; 133: 137
[Pubmed]  [Google Scholar] [DOI]
18 Advanced development of ErbB family-targeted therapies in osteosarcoma treatment
Wei Wang,Hua-fu Zhao,Teng-fei Yao,Hao Gong
Investigational New Drugs. 2018;
[Pubmed]  [Google Scholar] [DOI]
19 Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma
Jie Wu,Ai Guo,Qiang Li,Difan Wang
Future Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
20 Correlation between osteosarcoma and the expression of WWOX and p53
Pingtao Liu,Mingyue Wang,Li Li,Tao Jin
Oncology Letters. 2017; 14(4): 4779
[Pubmed]  [Google Scholar] [DOI]
21 Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis
Dong-dong Cheng,Hui-zhen Zhang,Jun-qing Yuan,Shi-jie Li,Qing-cheng Yang,Cun-yi Fan
Oncotarget. 2017; 8(16): 26380
[Pubmed]  [Google Scholar] [DOI]

 

Read this article